Underutilization of Aldosterone Antagonists in Heart Failure

Background: Treatment with an aldosterone antagonist (AA) has been shown in multiple trials to reduce heart failure (HF)–related morbidity, mortality, and hospital readmission. American College of Cardiology Foundation (ACCF) and American Heart Association (AHA) treatment guidelines recommend the us...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hosp Pharm
Autores principales: Patterson, Shanise J., Reaves, Anne B., Tolley, Elizabeth A., Ulrich, Dagny, Hilty, Christopher, Clarke, Catherine J., Self, Timothy H.
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2017
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5735744/
https://ncbi.nlm.nih.gov/pubmed/29276242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578717724886
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares